Tricks and Tips

Friday, February 19, 2016

Drug Safety Associate at Covance - Freshers

Dear Readers..!!! Thanks for visiting my blog...!!!

Manage the receipt and processing of all adverse event reports reported either spontaneously from any source or from a clinical trial. This includes, but is not limited to: 
Entry of safety data onto adverse event database(s) and tracking systems
Review of adverse events for completeness, accuracy and appropriateness for expedited reporting.
Write patient narratives
  • Code adverse events accurately using MedDRA
  • Determine expectedness/listedness against appropriate label
  • Identifies clinically significant information missing from initial reports and ensures its collection
  • Ensure case receives appropriate medical review
  • Prepare follow-up correspondence consulting the medical staff accordingly.
  • Ensure all cases that require expediting reporting to worldwide regulatory agencies are processed swiftly and appropriately within required timelines
  • Reporting of endpoints to clients, regulatory authorities, ethics committees, investigators and Covance project personnel, if required, within study specified timelines.
  • Maintain a strong understanding of Covance’s safety database conventions or client specific database conventions, as appropriate.
  • Begin participating in signal detection and trend and pattern recognition activities, as appropriate.
  • Begin preparing timely pharmacovigilance reports for products and safety issues, including Individual Case Summary Reports (ICSRs) of Serious Adverse Events
  • Assist in the preparation of listings for Annual IND reports, Periodic Reports (PRs) and Periodic Safety Update Reports (PSURs).
  • Work with Data Management or client on reconciliation of safety databases.
  • Begin participating in the generation of monthly status and other project-specific reports ensuring the quality and accuracy of metrics and data provided.
  • Support/train less experienced safety staff in all aspects of case-handling, adverse event reporting.
  • Maintains a comprehensive understanding of Covance Safety’s Standard Operating Procedures (SOPs), Work Instructions (WI), guidance documents and directives associated with safety management, reporting and pharmacovigilance.
  • Possess knowledge of other procedural documents, e.g., SOPs, etc. that impact Safety.
  • Ensure compliant safety reporting in accordance with US and international reporting regulations, SOPs and safety processing guidelines set forth by departmental management team and the client.
  • Build and maintain good PV&DSS relationships across functional units.
  • Demonstrate role-specific Competencies on a consistent basis.
  • Demonstrate company Values on a consistent basis.
  • Begin to develop a good knowledge of contract assumptions; identifying out of scope work.
  • Read and understand Safety Management Plans (SMPs), Reconciliation Plans, and other safety-specific plans ensuring optimal efficiency.
  • Begin participating in Covance project teams and client meetings as appropriate.
  • Assist in the review of cumulative safety data for submission to Drug Safety Monitoring Boards (DSMBs), regulatory authorities or clients.
  • Assist with the set-up of, and the provision of data to, Safety Committees/DSMBs.
  • Assist in the co-ordination of endpoint committees, as required.
  • Any other duties as assigned by management.
Education Required:
• Non-degree + 4-5 yrs relevant experience (or 2 yrs safety experience)*
• Associates Degree + 3-4 yrs relevant experience (or 1-2 yrs safety experience)*
• Associate degree RN + 2-3 yrs relevant experience (or 1-2 yrs safety experience)*
• BS/BA + 1-2 yrs relevant experience**
• MS/MA + 0 yr relevant experience**
• PharmD + 0 yrs relevant experience**


Degree preferred to be in one or more of the following disciplines: Biological Sciences, Pharmacy, Nursing, Life Sciences, and Chemistry.
*Safety experience includes actual experience processing AE/SAE reports, generating narratives, queries, working within safety databases, and experience with regulatory submissions.
**Relevant experience includes experience in the pharmaceutical, biotechnology, or CRO industry, partly in related areas such as Medical Affairs, Clinical Data Entry and Clinical Data Management, Clinical Data Monitor, Regulatory Affairs, or Quality Assurance.
• Speaking: English and local language.
• Writing/Reading: English and local language.


Experience Required:
• High degree of accuracy with attention to detail.
• Functions as a team player.
• Good Communication.
• Knowledge of medical and drug terminology desirable.
• Familiarity of Good Clinical Practice (GCP) related to clinical safety documentation.
• Familiarity with ICH Guidelines
• Familiarity of worldwide regulatory requirements and reporting of adverse event for both marketed and investigational products.
• Familiarity of worldwide regulatory requirements and reporting of adverse event for both marketed and investigational products.
• Good written and verbal communication skills.
• Ability to work independently with moderate supervision.
• Good keyboard skills, preferably with knowledge of MS office and Windows would be beneficial.

Apply Here

For more Updates, follow us on Facebook

Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Pharmacists Wanted for Dubai

Dear Readers..!!! Thanks for visiting my blog...!!!

Urgent requirement of Pharmacist for retail shops in Dubai for male candidates.
Qualification: B.Pharm, M.Pharm, MSc, BSc chemistry are eligible with or without experience.
Salary : AED 3000.00 for six months.
After DHA exam salary will be AED.5000.00
After one year salary will be AED.6000.00
MSc & BSc salary AED.3000.00
Free accommodation, free transportation & free medical benefits.
Mode of selection : CV
Contact number: 9037669901
Salary: INR 5,50,000 - 7,50,000 P.A

Desired Candidate Profile: Education- UG: B.Sc - Any Specialization, Chemistry, PG: M.Sc - Any Specialization, Chemistry. Doctorate: Any Doctorate - Any Specialization, Doctorate Not Required

Company Profile:


For more Updates, follow us on Facebook

Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Pharmacist -Fortis Hospital : Fresher

Dear Readers..!!! Thanks for visiting my blog...!!!
Job description: 
Issue & Return of Material against Patient indents from Stores and against Departmental indents.
Direct Issue of drugs/ medical consumable to Patient
Issue of Narcotics as per protocols
Receiving the material at Receiving Bay & Processing of Invoices.
Emergency Cash Purchase.
Receipt of consignment goods & Processing their Invoices on Consumption.
Physical Stock Verification.
Sale & return of material in OP Pharmacy.
Drug Expiry control and checking expires of medicine before dispensing to patients.
**Karnataka State Pharmacy Council Registration is mandate.

Role:Pharmacist/Chemist/Bio Chemist

Number of Openings: 5
Desired Candidate Profile: Education- UG: B.Pharma - Pharmacy, Diploma - Any Specialization. PG: M.Pharma - Pharmacy. Doctorate: Doctorate Not Required
Company Profile: Fortis Healthcare Ltd
Fortis Healthcare Limited is committed to clinical excellence and patient-centric healthcare, which is manifest in hospital design, patient services, medical programmes and the compassionate approach of medical and non-medical hospital staff. Fortis commissioned its first hospital in 2001 at Mohali, near Chandigarh, and has expanded its operations to become a network with an over 10,000 bed capacity across 68 hospitals.
Recruiter Name: Monika Priyadarshini
Contact Company: Fortis Healthcare Ltd
Telephone: 080-41994493

For more Updates, follow us on Facebook

Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Monday, January 18, 2016

Ask an Expert : Earn Credits: Modules @ BMJ Learning

Dear Readers..!!! Thanks for visiting my blog...!!!

Tanya is 33 and presents complaining of breakthrough bleeding with her contraceptive implant. It has been in situ for over two years and she has been getting altered bleeding for the last four months. She is up to date with her cervical cytology screening: her last one was taken 12 months ago and was normal. She had an STI screen six months ago and this was also normal.

How should you investigate and manage the patient in this scenario?


Dr Cindy Farmer offers expert answers to GPs’ questions on common practical challenges.


Key questions answered include:
  • What is the latest evidence regarding long term safety of the contraceptive implant and injection on bone density?
  • How important is family history when discussing contraception risks?
  • Changes in bleeding are so common in women taking hormonal contraception. When and how should I investigate this?
  • You can test your knowledge with case-based assessment questions at the end of the module and download a certificate of completion for your appraisal or training portfolio.
Other modules in the Ask an Expert series include:





Various Accreditation programmes offered through BMJ Learning that would fetch some credits.
AccreditorcreditAccreditation statement
ASCOFAME1:00 hourBMJ Learning has assigned 1 hour of CPD/CME credit to this module. BMJ Learning modules are being certified for ASCOFAME VIRTUAL (Colombia).
Australian College of Nursing
1 credit, 1:00 hourACN 3LP participants can claim 1 CNE point per hour of active learning for modules that are directly related to their area of nursing practice (no limit).
Austrian Academy of Physicians1 credit, 1:00 hourBMJ Learning modules have been certified for DFT Punkte. DFT Punkte are accepted in Austria
BMJ Learning1 credit, 1:00 hourBMJ Learning has assigned one hour of CPD/CME credit to the module and related journal article
Bahrain Defence Force Hospital1 credit, 1:00 hourThe Bahrain Defence Force Military Hospital represented by the Ministry of Defence Bahrain recognises BMJ Learning as being accredited for the purpose of continuous medical education (CME)/continuous professional development (CPD) in BDF. Healthcare professionals can thus claim continuous professional development credits for their activity in BMJ Learning. Completion of one module is considered the equivalent of one credit or one hour of learning.
Bhutan Medical and Health Council1 credit, 1:00 hourBhutan Medical and Health Council has formally accredited all BMJ Learning online modules for continuous professional development. Bhutan Medical and Health Council will accept the CME credit provided by BMJ Learning to any registered members of Bhutan Medical and Health Council for renewal of their registration.
Delhi Medical Council1 credit, 1:00 hourThe Delhi Medical Council recognises BMJ Learning as being accredited for the purpose of continuous medical education (CME)/continuous professional development (CPD). Doctors can thus claim continuous professional development credits for their activity in BMJ Learning. Completion of one module is considered the equivalent of 1 credit or 1 hour of learning.
Dubai Health Authority1 credit, 1:00 hourBMJ Learning is approved as a CME resource by the Dubai Health Authority (accreditation number 0254/11)
Iraqi Ministry of Health1 credit, 1:00 hourThe Iraq Ministry of Health has accredited BMJ Learning for the purposes of CME. One module is the equivalent of one hour or one credit point.
Kuwait Institute for Medical Specialization1 credit, 1:00 hourKuwait Institute for Medical Specialization (KIMS) of the Ministry of Health, State of Kuwait is the authority responsible for organising all aspects of postgraduate training of medical practitioners and other health professionals in Kuwait. Users within Kuwait can claim one hour or one credit per hour of learning completed.
Oman Medical Specialty Board0.5 creditsThe Oman Medical Specialty Board accredits this module for 0.5 credit points under Category II
Royal Australasian College of Physicians1:00 hourThe RACP does not accredit CPD activities, but MyCPD Program guidelines state that fellows can claim a maximum of 50 credits per year for online learning under 'Category 6 - Other Learning Activities'.
The Colleges of Medicine of South Africa3 creditsThe Colleges of Medicine of South Africa has accredited this BMJ Learning module (accreditation number: MDB014/254/06/2010)
The Royal New Zealand College of General Practitioners1 credit, 1:00 hourRNZCGP endorses the British Medical Journal online CME programmes
The Supreme Council of Health in Qatar1 credit, 1:00 hourThe Supreme Council of Health represented by the Accreditation Department of the Qatar Council for Health Practitioners recognizes the continuous medical education (CME)/continuing professional development (CPD) modules provided through BMJ Learning as Category II self-directed learning activities in the State of Qatar. Healthcare professionals in Qatar can thus claim continuing professional development credits for their activity on BMJ Learning, calculated as 1 credit unit per 1 hour (Organization Code OP-02).
Trinidad and Tobago Medical Association0.5 credits, 1:00 hourThe Trinidad and Tobago Medical Association has accredited BMJ Learning. One module equates to 0.5 credits.

For more Updates, follow us on Facebook

Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Bacteriology and Classification of Antibiotics : An Overview

Dear Readers..!!! Thanks for visiting my blog...!!!

Source : Unknown

CLASSIFICATION OF ANTIBIOTICS – SPECTRUM OF ACTIVITY

NARROW
INTERMEDIATE
BROAD
Penicillin G
Aminopenicillins
Tetracyclines
Streptomycin
Cephalosporins (2/3rd generations)
Chloramphenicol
Erythromycin
Fluoroquinolones


Newer macrolides



CLASSIFICATION OF ANTIBIOTICS – TYPE OF ACTION

BACTERIOSTATIC
BACTERIOCIDAL
Sulfonamides
Penicillins
Tetracyclines
Aminoglycosides
Chloramphenicol
Polypeptides
Erythromycin
Rifampin
Ethambutol
Cotrimoxazole
Clindamycin
Isoniazid
Linazolid
Cephalosporins

Vancomycin

Nalidixic acid

Ciprofloxacin

Metronidazole

Pyrazinamide


CEPHALOSPORINS

Generation
Parenteral
Oral
First
Cephalothin
Cefazolin

Cephalexin
Cephradine
Cefadroxil
Second
Cefuroxime
Cefoxitin

Cefaclor
Cefuroxime axetil
Cefprozil
Third
Cefotaxime
Ceftizoxime
Ceftriaxone
Ceftazidime
Cefoperazone
Cefixime
Cefpodoxime proxetil
Cefdinir
Ceftibuten
Ceftamet pivoxil
Fourth
Cefepime
Cefpirome

Fifth
Ceftobiprole
Ceftaroline
Ceftolozane


For more Updates, follow us on Facebook

Happy Blogging...!!!


Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Saturday, January 16, 2016

Woman behind every smile of a Cancer Patient : Salute Her

Dear Readers..!!! Thanks for visiting my blog...!!!

Today I would like to introduce you Her Excellency Prof. Dr. Gayatri Palat, MD - "a woman behind every smile of a cancer patient". Indeed its my privilege to be a trainee under the guidance of the team led by her. This team of MNJ institute of Oncology, INCTR, Pallium India and Two Worlds Cancer Collaboration has entirely changed my views and perceptions of Palliative care and approach towards the patient. The handwork, dedication, moral support and ethical approach shown by every member of the team is immense and they have once again proved how a team work can do miracles by bringing smiles in patients even at their end stage of life. 

Palliative Care for Children in a Resource Poor Setting, an Indian initiative
In Her words: 

Today, a child diagnosed with cancer in a developed country has an 80% chance of being cured. Unfortunately, this is not true in India where 75,000 children with recorded cancers each year have a survival rate of less than 20%. Furthermore, of the estimated 2.5 million people in India living with HIV/AIDS, 70,000 are children under the age of 15. Less than 0.4% of needy children have access to palliative care programs designed to address their needs.

Palliative Care for Children in the Mehdi Nawaj Jung (MNJ) Institute of Oncology (MNJIO), Hyderabad 

The MNJ Institute of Oncology is a 300 bed tertiary care hospital in the state of Andhra Pradesh, India (population of 65 million). Every year the hospital sees around 1,000 children with cancer.Most of the children require long, intensive curative treatment. Enormous suffering results from painful procedures, undesirable symptoms and the emotional trauma of facing potentially life threatening illnesses. Many children develop severe anxiety, depression and become withdrawn and non-communicative. Families often travel long distances and stay in the hospital for weeks and when the need for community and family support is greatest, they are totally deprived of it. Very early in our endeavour to cure these children, we realized the dire need for an effective palliative care program for both the children and their families as they confront cancer with all of its physical, psychosocial and spiritual effects. 

MNJIO Pain Relief and Palliative Care Program, a collaboration of the International Network for Cancer Treatment and Research (INCTR) and Pallium India added paediatric palliative care to their service in 2007. The primary goal of the program is zero-tolerance of pain beginning at diagnosis. Since the paediatric program was established, there has been a rapid increase in the number of children treated beginning with 69 patient visits in 2006 and 2,922 in 2010 ( Fig 1). 70% of children suffered from leukaemia and pain was the most common symptom at referral. Other common symptoms included mouth ulcers, constipation, vomiting and tiredness. The total opioid consumption for the year 2010 was 150gms. Every child undergoing interventions such as intrathecal or bone marrow injections received EMLA cream application +/- oral midazolam before the procedure. Other activities included regular weekly support groups, recreational and educational activities, home based care and regular and emergency telephonic consults.

A few successful outcomes of the program have been: 
  • almost all children receiving cancer treatment and their families are also receiving adequate symptom control and psychosocial support during curative treatment along with a smooth transition to end of life care if required, 
  • there has been a significant reduction in the dropout rate during treatment, and 
  • there is good implementation of procedure-related pain relief protocols. 
Scope of the program:

The paediatric pain and palliative care program is the first of its kind for the entire state of Andhra Pradesh. While the program is currently designed to cater only to the needs of children with cancer, we plan to expand it to include all children living with HIV and AIDS and other life threatening illnesses. A fellowship course in paediatric palliative care will start soon to train specialists in the field.

Hypertension : Explained Clearly by World class Instructors

Dear Readers..!!! Thanks for visiting my blog...!!!


Click on the image to view clearly

JNC - VIII Evidence Based Guidelines



For more Updates, follow us on Facebook

Happy Blogging...!!!
Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Friday, January 15, 2016

Psychological Distress in Cancer : Workshop @ IIT Hyderabad

Dear Readers..!!! Thanks for visiting my blog...!!!


Download the Brochure Here

For more Updates, follow us on Facebook

Happy Blogging...!!!
Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia